SMTL ID : 6ay6.1

Naegleria fowleri CYP51-voriconazole complex

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x VOR: Voriconazole(Non-covalent)

VOR.1: 12 residues within 4Å: Chain A: Y.82, F.89, Y.95, A.264, F.267, A.268, T.272, L.333, M.335, C.405, L.442 Ligands: HEM.2 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:F.89, A:Y.95, A:A.268

1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.2: 23 residues within 4Å: Chain A: Y.82, Y.95, G.265, A.268, G.269, T.272, S.273, P.332, L.333, I.336, R.338, P.397, F.398, G.399, R.402, H.403, K.404, C.405, I.406, G.407, F.410, A.411 Ligands: VOR.1 10 PLIP interactions: 10 interactions with chain A, Hydrophobic interactions: A:A.268, A:P.332, A:F.398, A:I.406, A:F.410, A:A.411 Hydrogen bonds: A:R.402 Salt bridges: A:R.338, A:H.403 Metal complexes: A:C.405

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Debnath, A. et al., CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM). PLoS Negl Trop Dis (2017)

Release Date

2017-11-22

Peptides

CYP51, sterol 14alpha-demethylase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

CYP51, sterol 14alpha-demethylase

Related Entries With Identical Sequence